Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 833

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 833
---
 any securities or over-the-counter exchange or market), and all other certificates, letters, statements, applications or other documents or information connected therewith, which may be required to be filed with the SEC, any state securities commission or otherwise with respect to such registration and offering, issuance, sale and resale of the Company Common Stock issuable upon conversion of the Series A Preferred Shares to be paid by the Company in the Merger and issuable upon conversion of the Series A Preferred Shares and with respect to any withdrawal of a Registration Statement, and to take any and all action that counsel for the Company shall advise or that the Authorized Officer taking such action shall determine to be necessary, advisable and appropriate; and be it further

#### Share Issuances
RESOLVED , that the issuances of shares of the Series A Preferred Shares to be paid by the Company in the Merger and the Series A Preferred Shares to be issued in connection with the Financing pursuant to the terms of the Merger Agreement and the Securities Purchase Agreement be, and hereby are, and authorized, adopted and approved in all respects; and be it further

RESOLVED , that upon issuance pursuant to the Merger Agreement and the Securities Purchase Agreement, the shares of Company Common Stock issuable upon conversion of the Series A Preferred Shares shall hereby be set aside out of the Company’s authorized shares of Company Common Stock as set forth below, and that upon issuance, all shares of Company Common Stock issuable upon conversion of the Series A Preferred Shares shall be validly issued, duly authorized and non-assessable; and be it further

RESOLVED , that in accordance with the Securities Purchase Agreement, the Company shall hereby set aside out of the authorized shares of Company Common Stock an aggregate of 150,000,000 shares of Company Common Stock (prior to giving effect to any Reverse Stock Split) (the “ Reserve Shares ”) for all shares of Company Common Stock collectively issuable upon conversion of all the Series A Preferred Shares then outstanding pursuant to the Securities Purchase Agreement, which number of Reserve Shares may be increased or decreased by the Company in accordance with the terms of the Securities Purchase Agreement; and be it further

#### Royalty Agreements
RESOLVED , that the form, terms and provisions of each Royalty Agreement, and the transactions contemplated thereby, be, and they hereby are, authorized, adopted and approved in all respects; and be it further

RESOLVED , that the Authorized Officer be, and he acting singly hereby is, authorized and directed, for and on behalf